Skip to main content
OpenTrials
Completed

NCT Number: NCT03089359

Prehospital Recognition and Identification of Unspecific Symptoms

This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Serious Condition Morality

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Helsinki University, Helsinki, Finland

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unspecific symptoms (not feeling well, decreased general health condition, unable to cope with usual daily activities, feeling weak)
  • Normal vital signs
  • Transported to ED
  • Able to give informed consent/ Next of kin gives informed consent

Exclusion criteria

  • Specific symptoms
  • under 18 years of age
  • Stays home / other caregiver than ED
  • Referral from caregiver
  • No personal numer (social security number)

Treatment and study plan

Primary outcomes

  1. Serious condition

    Time frame: During medical care event

    Predefined serious condition

Secondary outcomes

  1. Mortality

    Time frame: 24hours and 30 days

    24h and 30 day mortality

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Acronym: PRIUS

Important dates

Study start
2015
Primary completion
2021
Study completion
2021
First posted
Mar 24, 2017
Registry last updated
Mar 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.